Peptide record

TPDB92623

Test peptide Anticancer Neuropeptide modified_plain modified
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92623
Test peptide
Anticancer Neuropeptide
Cancer-related peptides Neuroactive peptides
CancerPPD 2.0 Peptipedia
modified_plain
Yes
A 5-aa modified multi-activity (Anticancer and Neuropeptide) peptide sequence curated from CancerPPD 2.0 and Peptipedia, with an available 3D structural model.
C-terminal: Amidation
Sequence
YSFGL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
5 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Anti cancer Activity
Neuropep Peptide Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 26.417±0.660 µM
Anticancer
26.417

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
48 h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 39.047±0.770 µM
Anticancer
39.047

Target

Lung Cancer
MDA-MB-231
Lung

Assay & Model

MTT assay
48 h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023